Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: John Metcalf who wrote (3236)	12/8/1997 9:21:00 PM
From: T. Mann	Read Replies (1) \| Respond to of 6136

Re:<<a used-car-sales-type in leisure suit and white shoes>> A friend of mine (who is a PhD scientist) has been interviewing for a position in Agouron a couple of years ago. Mr. Johnson was one of his interviewers. My friend's impression was actually pretty close to the description in the title. During the interview, they talked a lot about golf and Mr. Johnson told my friend that he had been in real estate business prior to founding Agouron. So I do not know where this <<brilliant researcher>> business came from. IMHO, a brilliant researcher running a company is a major negative from the investment point of view. Any biotech company is a business and should be run not by brilliant scientists but by brilliant businessmen. The scientists should stay in academia or big pharma. T.